Literature DB >> 11061510

Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.

S Reutrakul1, P M Sadow, S Pannain, J Pohlenz, G A Carvalho, P E Macchia, R E Weiss, S Refetoff.   

Abstract

The syndrome of resistance to thyroid hormone (RTH) is characterized by decreased tissue responsiveness to thyroid hormones. Inheritance is usually autosomal dominant due to mutations in the ligand-binding domain or adjacent hinge region of the thyroid hormone receptor beta (TRbeta) gene. Six of 65 families with the RTH phenotype studied in our laboratory had normal TRbeta1 and TRbeta2 gene sequences. Their clinical characteristics were not different from those of subjects with TRbeta gene mutations. Four of the 6 families were amenable to linkage analysis, and TRalpha involvement was excluded. Candidate genes were then evaluated for their possible involvement in the RTH phenotype in these 4 families: 2 coactivators [NCoA-1 (SRC-1) and NCoA-3 (AIB-1)], 2 corepressors (NCoR and SMRT), and a coregulator (RXRgamma). DNA was obtained from 8 affected subjects and 41 of 45 living first degree relatives. In 2 of the 4 families, the mode of inheritance could be determined by pedigree analysis and was found to be autosomal dominant. Linkage analyses were performed using polymorphic markers near or within the 5 candidate genes. When analyses were not informative or linkage could not be excluded, direct sequencing of the genes in question was performed. Involvement of NCoA-1 was excluded in all four families assuming autosomal dominant inheritance. Roles for NCoR, SMRT, and NCoA-3 were excluded in three and a role for RXRgamma was excluded in two of the four families. However, if the two families without proven dominant mode of inheritance were compound heterozygous, only the involvement of NCoA-1 could be excluded in both. Roles for NCoR, SMRT, and RXRgamma were excluded in one of these two families. Thus, NCoA-1 and RXRgamma genes were not found to be the cause of RTH in subjects without TR gene mutations even though the absence of NCoA-1 and RXRgamma is the cause of RTH in mice. Involvement of other candidate genes in the mediation of thyroid hormone action as well as intracellular hormone transport needs to be explored in these families with non-TRbeta, TRalpha RTH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11061510     DOI: 10.1210/jcem.85.10.6873

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Clinical and molecular features of a TSH-secreting pituitary microadenoma.

Authors:  Takeshi Usui; Shoichiro Izawa; Toshiaki Sano; Tetsuya Tagami; Daisuke Nagata; Akira Shimatsu; Jun A Takahashi; Mitsuhide Naruse
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Defects of Thyroid Hormone Synthesis and Action.

Authors:  Zeina C Hannoush; Roy E Weiss
Journal:  Endocrinol Metab Clin North Am       Date:  2017-03-06       Impact factor: 4.741

3.  Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.

Authors:  P Torre; M Bertoli; S Di Giovanni; S Scommegna; C Conte; G Novelli; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

4.  A case of Resistance to Thyroid Hormone without mutation in the thyroid hormone receptor beta.

Authors:  J H McDermott; A Agha; M McMahon; D Gasparro; L Moeller; A M Dumitrescu; S Refetoff; S Sreenan
Journal:  Ir J Med Sci       Date:  2005 Oct-Dec       Impact factor: 1.568

5.  [A 46-year-old patient with atrial fibrillation, elevated thyroid hormones and normal thyrotropine].

Authors:  I V Opherk; B Gutt; S Volz; T Siegmund; P M Schumm-Draeger
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

Review 6.  Germline and somatic thyroid hormone receptor mutations in man.

Authors:  P M Yen; S Y Cheng
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

7.  A novel splice variant involving the 5' untranslated region of thyroid hormone receptor beta1 (TRbeta1).

Authors:  D Mannavola; L C Moeller; P Beck-Peccoz; L Persani; R E Weiss; S Refetoff
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

8.  Refractory depression in a patient with peripheral resistance to thyroid hormone (RTH) and the effect of triiodothyronine treatment.

Authors:  Carlos E Fardella; Rocío A Artigas; Sergio Gloger; Marcela Jiménez; Cristian A Carvajal; Paola M Krall; Danilo Quiroz; Carmen Campino; Lorena M Mosso
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

9.  Syndrome of Reduced Sensitivity to Thyroid Hormones: Two Case Reports and a Literature Review.

Authors:  Anastasios Anyfantakis; Dimitrios Anyfantakis; Irene Vourliotaki
Journal:  Case Rep Endocrinol       Date:  2016-09-28

10.  A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms.

Authors:  Brijesh K Singh; Paul M Yen
Journal:  Clin Diabetes Endocrinol       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.